
- Did you mean
- argent
Search results - 8 results
Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.
Cervical Neoplasms Abstract: In 2012, VAL idation of human papillomavirus (HPV) GEN otyping T ests (VALGENT) was initiated to provide a formalized and uniform study framework for comparison and validation of ...
Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening.
(hrHPV) types is more effective than cytology-based screening. This study completes the diagnostic accuracy assessment conducted previously within the framework of VALGENT-2 (Validation of HPV genotyping ...
Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework.
Neoplasms Abstract: In this diagnostic test validation study, we assessed the clinical accuracy and HPV genotyping performance of the INNO-LiPA HPV Genotyping II (INNO-LiPA) within the VALGENT-3 framework. ...
Evaluation of the clinical performance of the HPV-Risk assay using the VALGENT-3 panel.
Abstract: Human papillomavirus (HPV) testing is being increasingly incorporated into cervical cancer screening. VALGENT (VAL idation of HPV GEN otyping Tests) is a framework designed to evaluate the clinical ...
Performance of a Cartridge-Based Assay for Detection of Clinically Significant Human Papillomavirus (HPV) Infection: Lessons from VALGENT (Validation of HPV Genotyping Tests).
(VALGENT) studies offer an opportunity to clinically validate HPV assays for use in primary screening for cervical cancer and also provide a framework for the comparison of analytical and type-specific ...
Clinical and analytical performance of the PapilloCheck HPV-Screening assay using the VALGENT framework.
context is essential, using well-annotated samples, such as those generated via the Validation of Genotyping Tests- HPV (VALGENT) framework. OBJECTIVE: Our aim was to assess the PapilloCheck HPV assay in ...
VALGENT: A protocol for clinical validation of human papillomavirus assays.
genotyping may be useful for triage in both HPV-based and cytology-based screening. Only clinically validated tests should be used in clinical practice. OBJECTIVES: VALGENT is a study framework for test ...
Clinical and Analytical Performance of the Onclarity HPV Assay Using the VALGENT Framework.
generated in the Validation of HPV Genotyping Tests (VALGENT) framework. Through VALGENT, we assessed the performance of the BD Onclarity HPV assay, which detects 14 high-risk (HR) types and resolves six ...